Novo, Pfizer Boost Metsera Bids in Obesity Startup Battle
Pfizer Inc. and Novo Nordisk A/S boosted their bids for obesity startup Metsera Inc. Novo’s updated offer values Metsera at a total of $10 billion, compared to the offer from...
By Bloomberg Markets · Bloomberg Markets
Pfizer Inc. and Novo Nordisk A/S boosted their bids for obesity startup Metsera Inc. Novo’s updated offer values Metsera at a total of $10 billion, compared to the offer from Pfizer, which values the company at about $8.1 billion. Madison Muller reports on Bloomberg Television. (Source: Bloomberg)